Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Revelation Biosciences, Inc.
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
August 09, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Tickers
REVB
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
June 24, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Tickers
REVB
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
June 13, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Tickers
REVB
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
May 10, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Tickers
REVB
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
March 22, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Tickers
REVB
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023
November 13, 2023
From
Revelation Biosciences, Inc.
Via
Business Wire
Tickers
REVB
Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering
July 26, 2022
From
Revelation Biosciences, Inc.
Via
GlobeNewswire
Tickers
REVB
REVBW
Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.
August 30, 2021
From
Revelation Biosciences, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.